- Company Directors - O
- Orbimed Capital Ii Llc
Insider Trading History of Orbimed Capital Ii Llc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Orbimed Capital Ii Llc since 2006.
The trader's CIK number is 1281668.
At the time of the last reporting, Orbimed Capital Ii Llc was the Director of Supernus Pharmaceuticals, Inc.. (stock ticker symbol SUPN).
Also see all insider trading activities at Supernus Pharmaceuticals, Inc..
Note that in the past
ORBIMED CAPITAL II LLC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Given Imaging Ltd (GIVN) by Orbimed Capital Ii Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | GIVN | 0 | $0 | 22,500 | $408,150 | 0 | $0 |
Yearly summary of insider trading at Avanir Pharmaceuticals (AVN) by Orbimed Capital Ii Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | AVN | 0 | $0 | 629,121 | $6,159,094 | 0 | $0 |
Yearly summary of insider trading at Supernus Pharmaceuticals, Inc. (SUPN) by Orbimed Capital Ii Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | SUPN | 0 | $0 | 302,183 | $2,281,120 | 0 | $0 |
| 2012 | SUPN | 0 | $0 | 297,815 | $2,062,337 | 0 | $0 |
Insider trading activities at 3 companies by Orbimed Capital Ii Llc:
1. Given Imaging Ltd (GIVN)
2. Avanir Pharmaceuticals (AVN)
3. Supernus Pharmaceuticals, Inc. (SUPN)
Table 1. Insider trading of Given Imaging Ltd (GIVN) by Orbimed Capital Ii Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-05-24 | GIVN | Sale | 22,500 | 18.14 | 408,150 |
Table 2. Insider trading of Avanir Pharmaceuticals (AVN) by Orbimed Capital Ii Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-05-31 | AVN | Sale | 629,121 | 9.79 | 6,159,094 |
Table 3. Insider trading of Supernus Pharmaceuticals, Inc. (SUPN) by Orbimed Capital Ii Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-02-13 | SUPN | Sale | 150,000 | 7.58 | 1,136,400 |
| 2013-02-12 | SUPN | Sale | 152,183 | 7.52 | 1,144,720 |
| 2012-12-18 | SUPN | Sale | 100,000 | 7.08 | 707,700 |
| 2012-12-17 | SUPN | Sale | 197,815 | 6.85 | 1,354,637 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Orbimed Capital Ii Llc
(Director of Supernus Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.